http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005247780-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ee0a2e22b55720bafed868812ff7e9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2b00c28472f372e05986a57fb6b7638
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74
filingDate 2004-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a732088f98ff5904a9d1a3f57f19bcc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2370fa372ca9235ec54b931c9bed8434
publicationDate 2005-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2005247780-A
titleOfInvention Viral hepatitis therapeutic agent
abstract PROBLEM TO BE SOLVED: To clarify that there has been a therapeutic effect of viral hepatitis which has not been known so far, about a culture and / or bacterial body of Bifidobacterium longum which is a kind of Bifidobacterium, and based on such knowledge To provide a completely new treatment for viral hepatitis. SOLUTION: A therapeutic agent for viral hepatitis comprising an anaerobic bacterium, Bifidobacterium longum culture and / or bacterial body as an active ingredient, and in particular, Bifidobacterium longum. A therapeutic agent for chronic hepatitis B and chronic hepatitis C, comprising as an active ingredient a culture undiluted solution, a culture supernatant obtained by culturing using a medium containing corn starch as a gelling agent is there. [Selection figure] None
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10149869-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10688177-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013259835-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9931398-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015503628-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9713630-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008010943-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013109635-A1
priorityDate 2004-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002332242-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03010297-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2712000-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002051792-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9047
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID29565
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID216816
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID29565
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415748
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92024010
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10407
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1681
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10407
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8434
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11103
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID216816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557062
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11103

Total number of triples: 43.